What is the 13F Pro Quality Score for CGC?

13F Pro ranks Canopy Growth Corp (CGC) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View CGC's current score at https://13fpro.ai/research/CGC (free sign-up required for the full ranking).

Which hedge funds own the most CGC stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of CGC include Toroso Investments,, MORGAN STANLEY, LAZARD ASSET MANAGEMENT. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/CGC as soon as new 13F filings post.

Where does 13F Pro source CGC data?

All Canopy Growth Corp fundamentals and ownership data come directly from SEC EDGAR. Canopy Growth Corp files with the SEC under CIK 1737927. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is CGC in?

Canopy Growth Corp (CGC) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is CGC research updated on 13F Pro?

CGC's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Canopy Growth Corp(CGC)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1737927 CGC stock profile & AI dashboard →

13F Pro Quality Score

20.1/100

Rank #2,681 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

30.4/100

Profitability

8.7/100

Balance Sheet

11.4/100

Earnings Quality

30.0/100

Free Cash Flow

12.2/100

Institutional Flow

11.5/100

Revenue Scale

29.1/100

Dilution Risk

47.0/100

CGC Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Canopy Growth Corp (CGC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CGC at 20.1/100 on a 32-signal composite quality model, placing it at rank #2,681 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include profitability (8.7) and balance sheet strength (11.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.0/100, reflecting ongoing share issuance or stock-based compensation. Top institutional holders of CGC by reported 13-F value include Toroso Investments,, MORGAN STANLEY, LAZARD ASSET MANAGEMENT, based on the most recent SEC filings. CGC trades on the Nasdaq exchange and files with the SEC under CIK 1737927. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CGC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Canopy Growth Corp directly from SEC EDGAR. Canopy Growth Corp's 13F Pro composite quality score has ranged between 8 and 46 since 2026, currently 20.1 — an improving long-term trajectory across 36 quarterly and live scoring snapshots.

✦

Fun facts about Canopy Growth Corp

Quirks, history, and lore behind CGC — the kind of stuff that makes a stock memorable.

1
The Basics
A Canadian company in a federally regulated industry · listed on Nasdaq and a major Canadian exchange · headquartered in Ontario.
2
The Numbers
Once valued at over $20 billion at its peak, it has since endured a brutal multi-year revenue decline and repeated restructuring — a cautionary tale in speculative markets.
3
The History
Founded around 2013, it rode a historic wave of legalization to become one of the world's largest producers in its category, briefly making its hometown a tourist attraction.
4
The Secret
Its former headquarters was a Hershey chocolate factory — the company repurposed the confectionery plant to grow something considerably more controversial.
5
The Lore
Constellation Brands — the wine and beer giant — famously invested nearly $4 billion in the company, a bet Wall Street is still raising an eyebrow at.
6
The Giveaway
It's the world's most recognizable cannabis company, traded under a ticker that sounds like it belongs in a Snoop Dogg playlist.

▶ Think you know your stocks? Play the Daily Ticker

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+5.8% YoY

$284.6MFY 2026

FY22 $475.7MFY24 $297.1MFY25 $269.0MFY26 $284.6M

Net Income

+48.3% YoY

$-262.9MFY 2026

FY22 $-310.0MFY24 $-693.7MFY25 $-508.9MFY26 $-262.9M

Operating Income

-38.0% YoY

$-161.7MFY 2026

FY22 $-1.02BFY24 $-228.7MFY25 $-117.1MFY26 $-161.7M

EPS (Diluted)

+81.4% YoY

$-0.88FY 2026

FY22 $-7.92FY24 $-9.27FY25 $-4.73FY26 $-0.88

Total Assets

+21.9% YoY

$1.12BFY 2026

FY22 $5.61BFY24 $1.30BFY25 $917.7MFY26 $1.12B

Total Debt

-19.0% YoY

$249.6MFY 2026

FY22 $1.51BFY24 $597.2MFY25 $308.3MFY26 $249.6M

Op. Cash Flow

+61.5% YoY

$-63.8MFY 2026

FY22 $-545.8MFY24 $-281.9MFY25 $-165.8MFY26 $-63.8M

Metric	FY 2026	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020
Revenue	$284.6M +5.8%	$269.0M -9.5%	$297.1M -37.5%	$475.7M -13.0%	$546.6M +37.1%	$398.8M
Net Income	$-262.9M +48.3%	$-508.9M +26.6%	$-693.7M -123.7%	$-310.0M +82.2%	$-1.74B -32.1%	$-1.32B
Operating Income	$-161.7M -38.0%	$-117.1M +48.8%	$-228.7M +77.6%	$-1.02B +18.1%	$-1.24B +25.5%	$-1.67B
EPS (Diluted)	$-0.88 +81.4%	$-4.73 +49.0%	$-9.27 -17.0%	$-7.92 -68.9%	$-4.69 -23.4%	$-3.80
Total Assets	$1.12B +21.9%	$917.7M -29.4%	$1.30B -76.8%	$5.61B -17.9%	$6.82B -0.5%	$6.86B
Total Debt	$249.6M -19.0%	$308.3M -48.4%	$597.2M -60.5%	$1.51B -5.2%	$1.59B +230.6%	$481.8M
Operating Cash Flow	$-63.8M +61.5%	$-165.8M +41.2%	$-281.9M +48.3%	$-545.8M -17.2%	$-465.7M +39.7%	$-772.6M

AI Insight: CGC Financial Trends

Canopy remains unprofitable despite debt reduction, but operating losses widened sharply in Q1 2026 after near-breakeven in Q3 2025.

• Total debt fell 55% from $561M in Q2 2024 to $250M in Q1 2026, improving leverage.

• Operating income deteriorated to –$96M in Q1 2026 from –$17M in Q3 2025, largest loss in 18 months.

• Revenue flat at ~$67–75M across last eight quarters; no growth trajectory evident.

• Net losses narrowed to –$2M in Q3 2025 but rebounded to –$157M in Q1 2026.

⚠ Operating margin collapsed to –135% in Q1 2026 versus –25% in Q3 2025; investigate Q1 expense spike.

⚠ Operating cash flow consistently negative despite debt paydown; sustainability of deleveraging at risk.

AI Insight: CGC Ratio Trends

Canopy Growth remains deeply unprofitable with deteriorating operational efficiency; operating margin collapsed to -134.4% in Q1 2026 while ROIC worsened to -40.5%.

• Operating margin deteriorated sharply from -25.3% in Q3 2025 to -134.4% in Q1 2026, signaling severe operational distress.

• ROIC declined to -40.5% in Q1 2026 from -29.6% in Q3 2025, destroying shareholder capital at accelerating pace.

• Debt-to-equity improved to 0.36 in Q1 2026 from 1.09 in Q3 2024, indicating some balance-sheet deleveraging.

⚠ Return metrics (ROE, ROA, ROIC) all deeply negative and volatile; no clear path to profitability visible in recent quarters.

⚠ Q1 2026 operating margin of -134.4% suggests one-time charges or exceptional weakness; monitor next quarter for stabilization.

Get alerted when CGC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Canopy Growth Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of CGC

Toroso Investments, LLC
$8.0M8,479,893 sh
MORGAN STANLEY
$1.9M1,969,640 sh
LAZARD ASSET MANAGEMENT LLC
$1.7M1,807,986 sh
GROUP ONE TRADING, L.P.
$1.7M1,749,800 sh
JANE STREET GROUP, LLC
$1.5M1,582,312 sh
CITADEL ADVISORS LLC
$1.4M1,451,600 sh
SIMPLEX TRADING, LLC
$1.3M1,371,400 sh
GOLDMAN SACHS GROUP INC
$1.2M1,263,602 sh
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$1.2M1,228,100 sh
CITADEL ADVISORS LLC
$1.1M1,131,028 sh

Fund	Value	Shares
Toroso Investments, LLC	$8.0M	8,479,893
MORGAN STANLEY	$1.9M	1,969,640
LAZARD ASSET MANAGEMENT LLC	$1.7M	1,807,986
GROUP ONE TRADING, L.P.	$1.7M	1,749,800
JANE STREET GROUP, LLC	$1.5M	1,582,312
CITADEL ADVISORS LLC	$1.4M	1,451,600
SIMPLEX TRADING, LLC	$1.3M	1,371,400
GOLDMAN SACHS GROUP INC	$1.2M	1,263,602
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.2M	1,228,100
CITADEL ADVISORS LLC	$1.1M	1,131,028

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put CGC on your watchlist

Track score changes the day Canopy Growth Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is CGC a good stock to buy?

13F Pro's AI-powered analysis of Canopy Growth Corp (CGC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CGC are available on the CGC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CGC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CGC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Canopy Growth Corp's investment landscape.